- Home
- Advocacy
- Latest News and Practice Data
- Previous Advocacy Updates
-
The FDA issued guidance to expand testing capacity by facilitating the development of molecular SARS-CoV-2 diagnostic assays (coronavirus).
-
Join state pathology leaders from across the country at the Pathologist Leadership Summit, May 2-5, 2020 on this page.
-
The House Ways & Means Committee overwhelmingly voted to support the CAP-backed Consumer Protections Against Surprise Medical Bills Act of 2020 to resolve billing disputes between insurers and physicians.
-
The House Ways and Means Committee released legislation that features provisions advocated for by the CAP to resolve billing disputes between insurers and physicians.
-
The CAP urged CMS to consider the complexity of pathology practice when requiring group health plans to disclose price and cost-sharing information.
-
The CAP, the AMA, and ten other physician groups engaged with Congress on developing bipartisan legislation that will protect patients from surprise bills and safeguard access to care.
-
The CAP and the AMA took issue with proposed scope of practice policy changes and their potential adverse impacts on the quality of patient care.
-
Solutions provided by the CAP allowed pathologists to prevent a -5% penalty to their Medicare reimbursement in 2020.
-
The CAP urged the CMS to adjust several proposed changes to the Medicare physician self-referral law, commonly referred to as the Stark law.
-
Before going to recess for 2019, Congress passed a $1.4 trillion spending package for 2020 and listened to the CAP’s concerns regarding rates for out-of-network care.
-
While Congress debated how to address surprise medical bills, the CAP mobilized pathologists to engage representatives and senators to ensure our views were heard.
-
The CAP urges Congress to address reimbursement for physician out-of-network services while it moves swiftly on surprise bills legislation. -
The CAP opposed a Horizon BlueCross BlueShield of NJ reimbursement policy that limits on units for surgical pathology and microscopic examination services.
-
At the 2019 AMA Interim Meeting, the CAP advocated to reinstate autopsy hospital standard and pushes back on step therapy protocols.
-
The CAP participated at the Clinical Laboratory Improvement Advisory Committee and sought to ensure regulations keep up with emerging technologies.
-
The CAP, the American Medical Association, and 100 other medical societies raised concerns in a recent letter to the Secretary of the Department of Health and Human Services regarding a proposal to loosen current Medicare scope of practice restraints.
-
The CAP will fight the sharp Medicare cuts to Pathologists finalized in 2020 Fee Schedule, while it did succeed in protecting pathology reporting measures.
-
CAP members met with congressional offices and urged them to back a fair payment formula and arbitration process when physicians’ services are unexpectedly provided out of network to patients.
-
The CAP, along with other physician specialties, applauded Reps. Raul Ruiz, MD (D-CA) and Phil Roe, MD (R-TN) for gaining 100 cosponsors for their bipartisan surprise medical bill legislation.
-
The CAP is urging its membership to directly contact government officials with their concerns for removing the requirement of an autopsy program as a condition for hospital participation in Medicare.
Contact Information